As one of the world's leading biology CROs, GenScript has established a comprehensive drug development platform to integrate antibody engineering and antibody production technologies. Our scientists, with extensive experience in antibody drug development, provide superior services such as single domain antibody generation, antibody humanization, affinity maturation and antibody sequencing.
The biopharmaceuticals market in the U.S. is expected to increase to $144 billion by 2016, with an annual growth rate of 11.2%. Monoclonal antibody (mAbs) drugs represent a primary sector of the biopharmaceuticals market. The specificity of mAbs has tremendous clinical value, making them highly effective therapeutic agents. Many large pharmaceutical companies are increasing their investment in mAb research after the success of drugs such as Remicade™ and Rituxan™.
|Antibody Sequencing Our fast turnaround ensures that your antibody project stays on track.||Antibody Humanization Our service reduces human immunogenicity while maintaining target affinity.|
|Biomolecular Interaction Analysis Our experienced scientists provide accuate analysis using state of the art technology.||Affinity Maturation Our phage display library and FASEBA technology can maximize antibody affinity.|
|Chimeric Antibody Generation A fast and inexpensive approach for generating therapeutic antibodies.||Antibody Library and Phage Display We can generate a library as fast as one month with scFv or Fab antibody libraries.|
|Epitope Mapping Our comprehensive service offers highly accurate epitope mapping.||Camelid Single Domain Antibody We are experienced in generating sdAbs for research and drug discovery.|
|Hybridoma Stabilization Your valuable clones will not lose productivity with our hybridoma stabilization service.||Anti-idiotype Monoclonal Antibody We can develop and test hybridomas expressing your anti-idiotype antibody.|
|Antigen Production We provide fast turnaround and the flexibility of choosing the expression system.||Antibody Transient Expression We can generate up to 50mg of antibody in as few as 8-12 weeks.|
|Premium Hybridoma Development We provide up to 100 high quality hybridomas to ensure success.||Antibody Stable Cell Line We offer production and industrial grade stable cell lines with MTX amplification and screening.|
|In-vitro Assay and Screening We offer comprehensive assays to determine the mechanisms of your antibody and antigen.||Antibody Production Our experienced scientists can scale-up antibody production by maximizing expression and purity.|
|In-vivo Efficacy and Safety We can determine the PK/PD profile of your antibody therapeutic with our efficacy and safety models.|